Colchester General Hospital

The trials here

What the 10 trials at this site are about, from their registry records.

Conditions

• Childhood cancers4 trials
• Prostate cancer3 trials
• Colorectal cancer1 trial
• Diffuse large B-cell lymphoma1 trial
• Glaucoma1 trial
• Head and neck cancer1 trial
• Kidney cancer1 trial
• Lung cancer1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 34 trials
• Phase 22 trials
• Phase 2/32 trials

Status

• Active, not recruiting5 trials
• Recruiting4 trials
• Completed1 trial

Lead sponsor

• University of Birmingham2 trials
• Cambridge University Hospitals NHS Foundation Trust1 trial
• Eli Lilly and Company1 trial
• Imperial College London1 trial
• iSTAR Medical1 trial
• and 4 more

Running trials

• Recruiting

  A Study Evaluating the Safety and Efficacy of MINIject S+ in Subjects With Open Angle Glaucoma

  NCT07009236· iSTAR Medical· Source

  Contact: Chrysostomos Dimitriou, Doctor

• Active, not recruiting

  A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)

  NCT05288166· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  Acalabrutinib in Combination With R-CHOP for Previously Untreated Diffuse Large B-cell Lymphoma (DLBCL)

  NCT04546620· Phase 2· University Hospital Southampton NHS Foundation Trust· Source

• Recruiting

  Renal Adjuvant MultiPle Arm Randomised Trial

  NCT03288532· Phase 3· University College, London· Source

  Contact: Muthu Kumar (principal investigator)

• Recruiting

  Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer

  NCT03150576· Phase 2/3· Cambridge University Hospitals NHS Foundation Trust· Source

  Contact: MB Mukesh (principal investigator)

• Recruiting

  Magnetic Resonance Tumour Regression Grade (mrTRG) as a Novel Biomarker - Phase III Non CTIMP Trial

  NCT02704520· Imperial College London· Source

  Contact: Lucy Thorogood

• Active, not recruiting

  CompARE: Escalating Treatment of Intermediate and High-risk Oropharyngeal Cancer (OPC)

  NCT04116047· Phase 3· University of Birmingham· Source

• Active, not recruiting

  Prostate Advances in Comparative Evidence

  NCT01584258· Phase 3· Royal Marsden NHS Foundation Trust· Source

• Active, not recruiting

  Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy

  NCT00268476· Phase 2/3· Medical Research Council· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers2 recruiting
• Colorectal cancer1 recruiting
• Glaucoma1 recruiting
• Kidney cancer1 recruiting
• Triple-negative breast cancer1 recruiting

Closed trials

• Completed

  National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer

  NCT02664935· Phase 2· University of Birmingham· Source